• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov5
AC Immune released FY2025 Q3 earnings on November 4 (EST), actual revenue USD 1.177 M (forecast USD 1.011 M), actual EPS USD -0.2006 (forecast USD -0.2294)
04:00
AC Immune released FY2025 9 Months earnings on November 4, 2025 (EST), actual revenue USD 3.933 M, actual EPS USD -0.6788
04:00
Aug6
AC Immune released FY2025 Semi-Annual Earnings on August 5, 2025 (EST) with actual revenue of USD 2.738 M and EPS of USD -0.477
03:00
AC Immune released FY2025 Q2 earnings on August 5 (EST), actual revenue USD 1.633 M (forecast USD 2.479 M), actual EPS USD -0.2625 (forecast USD -0.2188)
03:00
May15
AC Immune Rating Upgraded but Target Price Cut
07:41
May6
HC Wainwright Raises AC Immune's Q2 2025 Earnings Outlook
06:04

Schedules & Filings

Schedules
Filings
Nov4
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.177 M, Net Income -19.89 M, EPS -0.2006

Aug5
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.633 M, Net Income -26.49 M, EPS -0.2632

Apr30
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.123 M, Net Income -21.58 M, EPS -0.2149

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
22.060
+226.43%
+15.637
SMX
266.495
+89.00%
+125.495
GURE
8.630
+82.07%
+3.883
WHLR
5.745
+77.31%
+2.442
IRBT
4.219
+39.24%
+1.188
DBRG
12.910
+32.82%
+3.185
PAVS
0.0415
+31.75%
+0.011
PRAX
248.390
+30.75%
+58.420
ALMS
10.694
+28.84%
+2.394
TORO
5.280
+27.85%
+1.150
View More